ArticleBrain, behavior, & immunity - health2025

Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial.

Riccardo Bortoletto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.